PortfoliosLab logoPortfoliosLab logo
ESIH.DE vs. CIB0.DE
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

ESIH.DE vs. CIB0.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) (ESIH.DE) and VanEck Bionic Engineering UCITS ETF A (CIB0.DE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ESIH.DE vs. CIB0.DE - Yearly Performance Comparison


2026 (YTD)2025202420232022
ESIH.DE
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
-0.15%7.95%4.09%7.63%-1.51%
CIB0.DE
VanEck Bionic Engineering UCITS ETF A
-9.78%-10.00%5.16%2.09%-1.65%

Returns By Period

In the year-to-date period, ESIH.DE achieves a -0.15% return, which is significantly higher than CIB0.DE's -9.78% return.


ESIH.DE

1D
1.57%
1M
-4.69%
YTD
-0.15%
6M
5.41%
1Y
5.30%
3Y*
5.20%
5Y*
7.36%
10Y*

CIB0.DE

1D
1.37%
1M
-8.85%
YTD
-9.78%
6M
-3.29%
1Y
-11.01%
3Y*
-6.52%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ESIH.DE vs. CIB0.DE - Expense Ratio Comparison

ESIH.DE has a 0.18% expense ratio, which is lower than CIB0.DE's 0.55% expense ratio.


Return for Risk

ESIH.DE vs. CIB0.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ESIH.DE
ESIH.DE Risk / Return Rank: 2020
Overall Rank
ESIH.DE Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
ESIH.DE Sortino Ratio Rank: 1818
Sortino Ratio Rank
ESIH.DE Omega Ratio Rank: 1818
Omega Ratio Rank
ESIH.DE Calmar Ratio Rank: 2323
Calmar Ratio Rank
ESIH.DE Martin Ratio Rank: 2222
Martin Ratio Rank

CIB0.DE
CIB0.DE Risk / Return Rank: 22
Overall Rank
CIB0.DE Sharpe Ratio Rank: 33
Sharpe Ratio Rank
CIB0.DE Sortino Ratio Rank: 33
Sortino Ratio Rank
CIB0.DE Omega Ratio Rank: 33
Omega Ratio Rank
CIB0.DE Calmar Ratio Rank: 22
Calmar Ratio Rank
CIB0.DE Martin Ratio Rank: 00
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ESIH.DE vs. CIB0.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) (ESIH.DE) and VanEck Bionic Engineering UCITS ETF A (CIB0.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ESIH.DECIB0.DEDifference

Sharpe ratio

Return per unit of total volatility

0.28

-0.56

+0.84

Sortino ratio

Return per unit of downside risk

0.50

-0.68

+1.18

Omega ratio

Gain probability vs. loss probability

1.07

0.92

+0.15

Calmar ratio

Return relative to maximum drawdown

0.58

-0.70

+1.29

Martin ratio

Return relative to average drawdown

1.64

-1.80

+3.44

ESIH.DE vs. CIB0.DE - Sharpe Ratio Comparison

The current ESIH.DE Sharpe Ratio is 0.28, which is higher than the CIB0.DE Sharpe Ratio of -0.56. The chart below compares the historical Sharpe Ratios of ESIH.DE and CIB0.DE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ESIH.DECIB0.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.28

-0.56

+0.84

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.47

Sharpe Ratio (All Time)

Calculated using the full available price history

0.45

-0.25

+0.70

Correlation

The correlation between ESIH.DE and CIB0.DE is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

ESIH.DE vs. CIB0.DE - Dividend Comparison

Neither ESIH.DE nor CIB0.DE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ESIH.DE vs. CIB0.DE - Drawdown Comparison

The maximum ESIH.DE drawdown since its inception was -26.69%, roughly equal to the maximum CIB0.DE drawdown of -26.12%. Use the drawdown chart below to compare losses from any high point for ESIH.DE and CIB0.DE.


Loading graphics...

Drawdown Indicators


ESIH.DECIB0.DEDifference

Max Drawdown

Largest peak-to-trough decline

-26.69%

-26.12%

-0.57%

Max Drawdown (1Y)

Largest decline over 1 year

-13.44%

-15.52%

+2.08%

Max Drawdown (5Y)

Largest decline over 5 years

-26.69%

Current Drawdown

Current decline from peak

-8.97%

-24.58%

+15.61%

Average Drawdown

Average peak-to-trough decline

-7.14%

-9.86%

+2.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.55%

6.06%

-1.51%

Volatility

ESIH.DE vs. CIB0.DE - Volatility Comparison

iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) (ESIH.DE) and VanEck Bionic Engineering UCITS ETF A (CIB0.DE) have volatilities of 5.06% and 5.01%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ESIH.DECIB0.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.06%

5.01%

+0.05%

Volatility (6M)

Calculated over the trailing 6-month period

11.69%

12.42%

-0.73%

Volatility (1Y)

Calculated over the trailing 1-year period

19.22%

19.46%

-0.24%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

15.59%

17.80%

-2.21%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

15.45%

17.80%

-2.35%